Home Tools
Log in
Cart

Thrombopoietin Receptor

The thrombopoietin receptor also known as the myeloproliferative leukemia protein or CD110 (Cluster of Differentiation 110) is a protein that in humans is encoded by the MPL (myeloproliferative leukemia virus) oncogene.
Cat. No. Product name CAS No. Purity Chemical Structure
T67894 Butyzamide 1110767-45-7 98%
Butyzamide is an effective and oral Mpl activator. It is a novel non-peptide-based molecule with antagonistic effects on thrombopoietin (TPO) receptors, which pr...
T7417 Avatrombopag 570406-98-3 99.41%
Avatrombopag is a new oral thrombopoietin (TPO) receptor agonist, activating TPO receptor and increasing megakaryocytic proliferation/differentiation and platele...
T3882 4”-O-Glucosylvitexin 76135-82-5 99.43%
Glucosylvitexin inhibits TPO activity.
TQ0223 Lusutrombopag 1110766-97-6 99.74%
Lusutrombopag is an orally bioavailable, small molecule thrombopoietin (TPO) receptor agonist for chronic liver disease (CLD) patients with thrombocytopenia prio...
Butyzamide
T67894
Butyzamide is an effective and oral Mpl activator. It is a novel non-peptide-based molecule with antagonistic effects on thrombopoietin (TPO) receptors, which pr...
Avatrombopag
T7417
Avatrombopag is a new oral thrombopoietin (TPO) receptor agonist, activating TPO receptor and increasing megakaryocytic proliferation/differentiation and platele...
4”-O-Glucosylvitexin
T3882
Glucosylvitexin inhibits TPO activity.
Lusutrombopag
TQ0223
Lusutrombopag is an orally bioavailable, small molecule thrombopoietin (TPO) receptor agonist for chronic liver disease (CLD) patients with thrombocytopenia prio...